Warning letter
People's Custom Rx and Clinical Care, LLC: warning letter of Jun 6, 2016
FDA warning letter 494668 · New Orleans District Office
Key facts
| Reference number | 494668 |
|---|---|
| Company | People's Custom Rx and Clinical Care, LLC |
| Subject | CGMP/Compounded Drugs/Misbranding |
| Issue date | Jun 6, 2016 |
| Posted date | Jun 13, 2016 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 210, 211 |
| Inspection city | Memphis |
| Inspection ZIP | 38117 |
| Inspection start date | Jul 20, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: